Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2024-2032

The global autoinjector market market size reached US$ 2.2 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2023-2032.

Autoinjectors are self-injectable devices that help deliver drugs via the subcutaneous or intramuscular route. They offer several advantages, such as dosage accuracy and improved patient compliance, and help reduce needle phobia of patients, lower needlestick injuries resulting from a hidden needle, and increase the convenience and efficiency of healthcare professionals. They are widely used during emergency conditions, such as anaphylaxis, migraine, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. As a result, autoinjectors find extensive applications in hospitals, clinics, and home care centers across the globe.

Autoinjector Market Trends:

At present, there is a rise in the prevalence of arthritis, asthma, cancer, chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease. This, along with the growing need for self-administrating medicines, represents one of the key factors driving the market. Moreover, governments of several countries are undertaking initiatives to promote the use of autoinjectors in schools. This, coupled with the increasing awareness among individuals about the benefits of autoinjectors, is propelling the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to develop simple, cost-effective, and new technology-based autoinjectors for treating rheumatoid arthritis and multiple sclerosis. Besides this, the rising adoption of targeted therapies to alter proteins within cancer cells and prevent the formation of new blood vessels in the tumor is offering lucrative growth opportunities to industry investors. Additionally, the burgeoning healthcare industry around the world is bolstering the growth of the market. Some of the other factors inducing growth are the increasing number of regulatory approvals, technological advancements, patent expiry of biologics and the availability of generic versions of autoinjectors.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global autoinjector market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Disposable Autoinjectors
Reusable Autoinjectors

Breakup by Application:

Rheumatoid Arthritis
Anaphylaxis
Multiple Sclerosis
Others

Breakup by End User:

Home Care Settings
Hospitals and Clinics

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Key Questions Answered in This Report

1. What was the size of the global autoinjector market in 2023?
2. What is the expected growth rate of the global autoinjector market during 2024-2032?
3. What are the key factors driving the global autoinjector market?
4. What has been the impact of COVID-19 on the global autoinjector market?
5. What is the breakup of the global autoinjector market based on the type?
6. What is the breakup of the global autoinjector market based on the application?
7. What is the breakup of the global autoinjector market based on the end user?
8. What are the key regions in the global autoinjector market?
9. Who are the key players/companies in the global autoinjector market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Autoinjector Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Disposable Autoinjectors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reusable Autoinjectors
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Application

7.1 Rheumatoid Arthritis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anaphylaxis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Multiple Sclerosis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by End User

8.1 Home Care Settings
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals and Clinics
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by Region

9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Antares Pharma Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eisai Co. Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Eli Lilly and Company
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Haselmeier GmbH (Sulzer Ltd.)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Johnson & Johnson
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Mylan N.V. (Viatris Inc.)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Novartis AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 SHL Medical AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Teva Pharmaceutical Industries Ltd.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Ypsomed Holding AG
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Autoinjector Market: Major Drivers and Challenges
Figure 2: Global: Autoinjector Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Autoinjector Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Autoinjector Market: Breakup by Type (in %), 2023
Figure 5: Global: Autoinjector Market: Breakup by Application (in %), 2023
Figure 6: Global: Autoinjector Market: Breakup by End User (in %), 2023
Figure 7: Global: Autoinjector Market: Breakup by Region (in %), 2023
Figure 8: Global: Autoinjector (Disposable Autoinjectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Autoinjector (Disposable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Autoinjector (Reusable Autoinjectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Autoinjector (Reusable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Autoinjector (Rheumatoid Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Autoinjector (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Autoinjector (Anaphylaxis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Autoinjector (Anaphylaxis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Autoinjector (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Autoinjector (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Autoinjector (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Autoinjector (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Autoinjector (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Autoinjector (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Autoinjector (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Autoinjector (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Autoinjector Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Autoinjector Industry: SWOT Analysis
Figure 74: Global: Autoinjector Industry: Value Chain Analysis
Figure 75: Global: Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Autoinjector Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Autoinjector Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Autoinjector Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Autoinjector Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Autoinjector Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Autoinjector Market: Competitive Structure
Table 7: Global: Autoinjector Market: Key Players

Companies Mentioned

Amgen Inc.
Antares Pharma Inc.
Becton Dickinson and Company
Bristol-Myers Squibb Company
Eisai Co. Ltd.
Eli Lilly and Company
Haselmeier GmbH (Sulzer Ltd.)
Johnson & Johnson
Mylan N.V. (Viatris Inc.)
Novartis AG
SHL Medical AG
Teva Pharmaceutical Industries Ltd.
Ypsomed Holding AG.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	149
Published	July 2024
Forecast Period	2023 - 2032
Estimated Market Value ( USD ) in 2023	$ 2.2 Billion
Forecasted Market Value ( USD ) by 2032	$ 7.4 Billion
Compound Annual Growth Rate	14.4%
Regions Covered	Global
No. of Companies Mentioned	13

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3812EUR$3,899USD£3,184GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4789EUR$4,899USD£4,000GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5767EUR$5,899USD£4,817GBP

Autoinjector Market Trends:

Key Market Segmentation:

Breakup by Type:

Breakup by Application:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2024-2032

Autoinjectors Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

Autoinjectors - Market Insights, Competitive Landscape, and Market Forecast - 2030

Epinephrine Autoinjectors - Global Strategic Business Report